Search

everythinglearnresearchcommunity

for

Search:↓

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Finasteride reduces some inflammation in BPH but not all.

The new compound may be a safer alternative to finasteride for prostate protection.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Bitter melon extract may help prevent hair loss and can be used in cosmetic products.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Finasteride use may increase suicidality risk, especially in young men.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

Taking medication for hair loss might cause sexual problems.